Financial News
Johnson & Johnson shares slip after jury orders it to pay $29 million in latest talcum cancer trial
March 13, 2019 at 20:41 PM EDT
A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
